About BRAK Labs

What this site is

A reference for a category that badly needs one. Peptides are discussed constantly and documented poorly. Most of what a reader finds is either a vendor describing a product or a forum describing a feeling.

Every compound gets the same treatment here. What it is, chemically and in plain words. What people use it for. What has actually been studied, in whom, at what scale, and what those studies measured. Where the regulator stands today, with the actual documents cited. And an evidence tier on every claim about what a compound does, so a reader can see at a glance whether a statement rests on a human trial, an animal study, a cell culture, or a forum post.

The grading is the point. In this category almost nothing has a completed human trial behind it, and a site that reports that plainly is more useful than one that does not. Knowing that a claim is supported by rodent work is real information. It tells the reader exactly how much weight the claim carries.

BRAK Labs sells nothing

There is no cart, no price, no product page, and no order button anywhere on this site. We do not sell peptides, supplements, tests, consultations, courses, or subscriptions. We hold no inventory and take no payments.

That is a structural choice, not a temporary state. A site that sells a compound and also explains it has an interest in the explanation. Taking the sale off this domain removes the transaction, and it removes the reason to shade a page toward a checkout.

It does not remove every interest, and saying otherwise would be the first dishonest sentence on the site. The people who publish BRAK Labs have a commercial interest in the sale of peptide products elsewhere. That is stated in full in the conflict of interest section of the editorial policy, along with how any commercial link is marked and what we will not do because of it.

What this site does not do

• It does not give medical advice. Nothing here is a diagnosis, a treatment plan, or a recommendation about your health. Talk to a licensed clinician about anything concerning your health.
• It does not publish doses or protocols. No amounts stated as instructions, no schedules, no cycles, no reconstitution steps, no injection technique. Where dosing figures circulate publicly, we report that they circulate and name the source class. We do not tell anyone to follow them.
• It does not publish results timelines or before-and-after imagery. Neither belongs on an editorial page about a compound with no completed human trial.
• It does not say anything is safe. We report what was measured, in what species, at what exposure. Safety is a conclusion the published record does not support for most of these compounds, in either direction.
• It does not review vendors. No rankings, no star ratings, no "best of" lists, and no claims about the quality of any named company's product. Our sourcing coverage describes what a credible certificate of analysis looks like. It never says who issues a bad one.
• It does not publish testimonials. A user account of an outcome is not evidence and it is not published here as though it were.

The full list is in the editorial policy, and the reasoning behind it is in the medical disclaimer.

Who publishes it

BRAK Labs publishes under an organization byline. Pages are written and reviewed against the standards on the editorial policy page, and the organization is accountable for every one of them.

No article here is attributed to a named individual, and no article here claims a medical reviewer. That is deliberate. Three patterns are common in this category and each one is worse than publishing without a named reviewer: a placeholder left where a reviewer's name should be, authority borrowed from public figures who had nothing to do with the writing, and credentials that do not match the subject.

An honest organization byline beats all three. When a credentialed reviewer is retained, that person will be named, their credentials will be checkable, and the pages they reviewed will say so with the date.

Who publishes this, and how it is funded

BRAK Labs is published by people who also have a commercial interest in the sale of peptide products. It is not an independent publisher and it does not claim to be. That is the first thing to know about this site, so it is here rather than further down, and the full arrangement is set out in the conflict of interest section of the editorial policy.

What that buys the reader is worth being precise about. Coverage is not conditioned on the relationship: a compound sold by a connected storefront gets the same evidence tiers, the same claim strength matrix, and the same negative-space section as one nobody sells. No compound is graded up because it is stocked, and none is graded down because it is not. Disclosure reduces this problem rather than removing it, and a reader who wants a source with no commercial connection to the category should use one.

Today BRAK Labs carries no advertising, no sponsored posts, no affiliate links, and no links to any store. Nothing on this site earns money at the moment you read it.

That will change, and the change will be visible. If a commercial link ever appears on this site it will carry a visible disclosure next to the link itself, on the same page, in the same block, along with rel="sponsored nofollow" in the markup. It will not be hidden in a footer, behind an asterisk, or inside a hyperlink that says "disclosure". The editorial policy commits to that in writing before there is anything to disclose, which is the only time such a commitment is worth making.

Reaching us

Two addresses, both read by a person.

• editor@braklabs.com for coverage requests, source suggestions, questions about the standards, and press.
• corrections@braklabs.com for anything you believe is wrong. Point at the page and the sentence. Corrections are published in the corrections log rather than edited away quietly.